Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
scott_klarenbach [2022/10/25 07:17]
liam | scott_klarenbach [2022/10/26 23:16] (current)
liam |
|---|
| {{ ::scottklarenbach.jpeg?200|}} | {{ ::scottklarenbach.jpeg?200|}} |
| |
| Dr. **Scott Klarenbach**, MD, MSc, FRCPC is a Canadian nephrologist. | Dr. **Scott Klarenbach**, MD, MSc, FRCPC is a Canadian nephrologist. He is co-chair of the [[AHS COVID-19 Scientific Advisory Group]] under [[Alberta Health Services]]. |
| |
| ===== Education ===== | ===== Education ===== |
| === Real-World Evidence Consortium === | === Real-World Evidence Consortium === |
| |
| Klarenbach is Director of the [[Real-World Evidence Consortium]] at the [[University of Calgary]], which conducts pharmacoepidemiologic and pharmacoeconomic research.((Klarenbach, S. (2022, May 12). //Disclosure Form.// Canadian Task Force on Preventative Health Care. https://web.archive.org/web/20221025043248/https://canadiantaskforce.ca/wp-content/uploads/2022/06/Disclosure-June2022-Klarenbach.pdf)) In his declaration of interest from June 2022, Klarenbach noted that the success of RWEC "is contingent on industry funding", though he doesn't receive any honoraria himself. | Klarenbach is Director of the [[Alberta Real-World Evidence Consortium]] at the [[University of Calgary]], which conducts pharmacoepidemiologic and pharmacoeconomic research.((Klarenbach, S. (2022, May 12). //Disclosure Form.// Canadian Task Force on Preventative Health Care. https://web.archive.org/web/20221025043248/https://canadiantaskforce.ca/wp-content/uploads/2022/06/Disclosure-June2022-Klarenbach.pdf)) In his declaration of interest from June 2022, Klarenbach noted that the success of RWEC "is contingent on industry funding", though he doesn't receive any honoraria himself. |
| |
| ==== Research ==== | ==== Research ==== |
